DIN 02499681 — ENSPRYNG 120 MG
ENSPRYNG is a solution of Satralizumab marketed by HOFFMANN-LA ROCHE LIMITED. The full Satralizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02499681
- Brand name
- ENSPRYNG
- Active ingredient
- Satralizumab
- Strength
- 120 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Interleukin-6 receptor inhibitor (immunosuppressant monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.